Napp Pharmaceuticals (United Kingdom)

Recent papers from Napp Pharmaceuticals (United Kingdom)

1. Abstract 470: JZP898, a conditionally activated interferon alpha, generates efficacy and robust TME engagement in syngeneic mouse models.Cancer Research · 2026
2. The Impact of the Fungal Priority Pathogens List on Medical Mycology: A Northern European PerspectiveOpen Forum Infectious Diseases · 2024
3. Scalable Palladium-Catalyzed C(sp3)–H Carbonylation of Alkylamines in Batch and Continuous FlowOrganic Process Research & Development · 2023
4. Functional genomics provide key insights to improve the diagnostic yield of hereditary ataxiaBrain · 2023
5. Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstructionAnnals of Allergy Asthma & Immunology · 2022
6. Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD ModelDiabetes Therapy · 2020
7. Circulating interleukin‐6 as a biomarker in a randomized controlled trial of modified‐release prednisone vs immediate‐release prednisolone, in newly diagnosed patients with giant cell arteritisInternational Journal of Rheumatic Diseases · 2019
8. A retrospective observational study of early experiences of vedolizumab treatment for inflammatory bowel disease in the UKMedicine · 2019
9. Gene Expression Profiling of Transcription Factors of Helicobacter pylori under Different Environmental ConditionsFrontiers in Microbiology · 2017
10. Satisfaction, Adherence and Health-Related Quality of Life with Transdermal Buprenorphine Compared with Oral Opioid Medications in the Usual Care of Osteoarthritis PainPatient · 2016
11. An evaluation of comparative treatment effects with high and low dose fluticasone propionate/formoterol combination in asthmaPulmonary Pharmacology & Therapeutics · 2015
12. Structure and stability of two polymorphs of creatine and its monohydrateCrystEngComm · 2014
13. Ionic co-crystals of racetams: solid-state properties enhancement of neutral active pharmaceutical ingredients via addition of Mg2+ and Ca2+ chloridesCrystEngComm · 2014
14. Structural assignment of a bis-cyclopentenyl-β-cyanohydrin formedviaalkene metathesis from either a triene or a tetraene precursorActa Crystallographica Section C Crystal Structure Communications · 2013
15. Discovery of 4-{4-[(3R)-3-Methylmorpholin-4-yl]-6-[1-(methylsulfonyl)cyclopropyl]pyrimidin-2-yl}-1H-indole (AZ20): A Potent and Selective Inhibitor of ATR Protein Kinase with Monotherapy in Vivo Antitumor ActivityJournal of Medicinal Chemistry · 2013
16. Quality of life benefits and cost impact of prolonged release oxycodone/naloxone versus prolonged release oxycodone in patients with moderate-to-severe non-malignant pain and opioid-induced constipation: a UK cost-utility analysisJournal of Medical Economics · 2012
17. Mechanistic Modeling of Antigen Sink Effect for Mavrilimumab Following Intravenous Administration in Patients With Rheumatoid ArthritisThe Journal of Clinical Pharmacology · 2011
18. Fifty-year old samples of progesterone demonstrate the complex role of synthetic impurities in stabilizing a metastable polymorphCrystEngComm · 2011
19. Population preference values for treatment outcomes in chronic lymphocytic leukaemia: a cross-sectional utility studyHealth and Quality of Life Outcomes · 2010
20. Blind crystal structure prediction of a novel second polymorph of 1-hydroxy-7-azabenzotriazoleActa Crystallographica Section B Structural Science · 2006